BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baragli A, Ghè C, Arnoletti E, Granata R, Ghigo E, Muccioli G. Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B. Biochim Biophys Acta. 2011;1811:386-396. [PMID: 21435395 DOI: 10.1016/j.bbalip.2011.03.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Cervone DT, Lovell AJ, Dyck DJ. Regulation of adipose tissue and skeletal muscle substrate metabolism by the stomach-derived hormone, ghrelin. Current Opinion in Pharmacology 2020;52:25-32. [DOI: 10.1016/j.coph.2020.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Chen Y, Chiang C, Chen L, Liao S, Hsieh W, Lin W. Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues. Biomaterials 2014;35:2051-65. [DOI: 10.1016/j.biomaterials.2013.11.051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
3 Cervone DT, Sheremeta J, Kraft EN, Dyck DJ. Acylated and unacylated ghrelin directly regulate ß-3 stimulated lipid turnover in rodent subcutaneous and visceral adipose tissue ex vivo but not in vivo. Adipocyte 2019;8:1-15. [PMID: 30265180 DOI: 10.1080/21623945.2018.1528811] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Porteiro B, Díaz-Ruíz A, Martínez G, Senra A, Vidal A, Serrano M, Gualillo O, López M, Malagón MM, Diéguez C. Ghrelin requires p53 to stimulate lipid storage in fat and liver. Endocrinology. 2013;154:3671-3679. [PMID: 23832961 DOI: 10.1210/en.2013-1176] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
5 Huang L, Sherchan P, Wang Y, Reis C, Applegate RL 2nd, Tang J, Zhang JH. Phosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury. J Neurosci 2015;35:10390-401. [PMID: 26203135 DOI: 10.1523/JNEUROSCI.0546-15.2015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
6 Schmidt C, Schneble N, Müller JP, Bauer R, Perino A, Marone R, Rybalkin SD, Wymann MP, Hirsch E, Wetzker R. Phosphoinositide 3-kinase γ mediates microglial phagocytosis via lipid kinase-independent control of cAMP. Neuroscience 2013;233:44-53. [PMID: 23276671 DOI: 10.1016/j.neuroscience.2012.12.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
7 Callaghan B, Furness JB, Christopoulos A. Novel and Conventional Receptors for Ghrelin, Desacyl-Ghrelin, and Pharmacologically Related Compounds. Pharmacol Rev 2014;66:984-1001. [DOI: 10.1124/pr.113.008433] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 8.5] [Reference Citation Analysis]
8 Meltzer-Mats E, Babai-Shani G, Pasternak L, Uritsky N, Getter T, Viskind O, Eckel J, Cerasi E, Senderowitz H, Sasson S, Gruzman A. Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives. J Med Chem 2013;56:5335-50. [PMID: 23750537 DOI: 10.1021/jm4001488] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
9 Rodríguez A, Gómez-Ambrosi J, Catalán V, Rotellar F, Valentí V, Silva C, Mugueta C, Pulido MR, Vázquez R, Salvador J, Malagón MM, Colina I, Frühbeck G. The ghrelin O-acyltransferase-ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia 2012;55:3038-50. [PMID: 22869322 DOI: 10.1007/s00125-012-2671-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
10 Miao H, Pan H, Wang L, Yang H, Zhu H, Gong F. Ghrelin Promotes Proliferation and Inhibits Differentiation of 3T3-L1 and Human Primary Preadipocytes. Front Physiol 2019;10:1296. [PMID: 31681009 DOI: 10.3389/fphys.2019.01296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Chopin LK, Seim I, Walpole CM, Herington AC. The ghrelin axis--does it have an appetite for cancer progression? Endocr Rev 2012;33:849-91. [PMID: 22826465 DOI: 10.1210/er.2011-1007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
12 Bergan HE, Kittilson JD, Sheridan MA. PKC and ERK mediate GH-stimulated lipolysis. Journal of Molecular Endocrinology 2013;51:213-24. [DOI: 10.1530/jme-13-0039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
13 Kołodziejski PA, Pruszyńska-oszmałek E, Korek E, Sassek M, Szczepankiewicz D, Kaczmarek P, Nogowski L, Maćkowiak P, Nowak KW, Krauss H, Strowski MZ. Serum Levels of Spexin and Kisspeptin Negatively Correlate With Obesity and Insulin Resistance in Women. Physiol Res. [DOI: 10.33549/physiolres.933467] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
14 Benso A, Gramaglia E, Olivetti I, Tomelini M, Belcastro S, Calvi E, Dotta A, St-Pierre D, Ghigo E, Broglio F. Acute effects of acylated ghrelin on salbutamol-induced metabolic actions in humans. Endocrine 2015;48:937-41. [PMID: 25012253 DOI: 10.1007/s12020-014-0343-6] [Reference Citation Analysis]
15 Kraft EN, Cervone DT, Dyck DJ. Ghrelin stimulates fatty acid oxidation and inhibits lipolysis in isolated muscle from male rats. Physiol Rep 2019;7:e14028. [PMID: 30963694 DOI: 10.14814/phy2.14028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Delhanty PJ, Neggers SJ, van der Lely AJ. Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl ghrelin. Eur J Endocrinol. 2012;167:601-608. [PMID: 22898499 DOI: 10.1530/eje-12-0456] [Cited by in Crossref: 151] [Cited by in F6Publishing: 63] [Article Influence: 15.1] [Reference Citation Analysis]
17 Sheriff S, Kadeer N, Friend LA, James JH, Alexander JW, Balasubramaniam A. Des-acyl-ghrelin (DAG) normalizes hyperlactacidemia and improves survival in a lethal rat model of burn trauma. Peptides. 2014;60:1-7. [PMID: 25063053 DOI: 10.1016/j.peptides.2014.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
18 Pei XM, Yung BY, Yip SP, Chan LW, Wong CS, Ying M, Siu PM. Protective effects of desacyl ghrelin on diabetic cardiomyopathy. Acta Diabetol 2015;52:293-306. [PMID: 25192951 DOI: 10.1007/s00592-014-0637-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
19 Garcia JM. What is next after anamorelin? Curr Opin Support Palliat Care 2017;11:266-71. [PMID: 28957883 DOI: 10.1097/SPC.0000000000000299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
20 Maugham ML, Seim I, Thomas PB, Crisp GJ, Shah ET, Herington AC, Brown KA, Gregory LS, Nelson CC, Jeffery PL, Chopin LK. No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction. PLoS One 2018;13:e0198495. [PMID: 30458004 DOI: 10.1371/journal.pone.0198495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Baragli A, Lanfranco F, Allasia S, Granata R, Ghigo E. Neuroendocrine and metabolic activities of ghrelin gene products. Peptides. 2011;32:2323-2332. [PMID: 22056513 DOI: 10.1016/j.peptides.2011.10.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
22 Frühbeck G, Méndez-Giménez L, Fernández-Formoso JA, Fernández S, Rodríguez A. Regulation of adipocyte lipolysis. Nutr Res Rev. 2014;27:63-93. [PMID: 24872083 DOI: 10.1017/s095442241400002x] [Cited by in Crossref: 202] [Cited by in F6Publishing: 108] [Article Influence: 25.3] [Reference Citation Analysis]
23 Samidurai A, Xi L, Das A, Iness AN, Vigneshwar NG, Li PL, Singla DK, Muniyan S, Batra SK, Kukreja RC. Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities. Pharmacol Ther 2021;226:107858. [PMID: 33895190 DOI: 10.1016/j.pharmthera.2021.107858] [Reference Citation Analysis]
24 Diao HY, Shao JG, Bian ZL, Chen L, Ju LL, Zhang Y. Role of phosphoinositide-3 kinase signaling pathways in pathogenesis of acute pancreatitis. Shijie Huaren Xiaohua Zazhi 2016; 24(19): 3002-3008 [DOI: 10.11569/wcjd.v24.i19.3002] [Reference Citation Analysis]
25 Granata R, Gallo D, Luque RM, Baragli A, Scarlatti F, Grande C, Gesmundo I, Córdoba-Chacón J, Bergandi L, Settanni F, Togliatto G, Volante M, Garetto S, Annunziata M, Chanclón B, Gargantini E, Rocchietto S, Matera L, Datta G, Morino M, Brizzi MF, Ong H, Camussi G, Castaño JP, Papotti M, Ghigo E. Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 2012;26:3393-411. [PMID: 22601779 DOI: 10.1096/fj.11-201343] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
26 Gesmundo I, Gallo D, Favaro E, Ghigo E, Granata R. Obestatin: a new metabolic player in the pancreas and white adipose tissue. IUBMB Life 2013;65:976-82. [PMID: 24217898 DOI: 10.1002/iub.1226] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]